Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Ann Intern Med. 2022 Jul 12;175(8):1083–1091. doi: 10.7326/M21-3846

Table 1.

Overview of Study Participants With Chronic HCV Infection at the First LSM Visit (n = 1323)*

Characteristic Value
Median age (IQR), y 49 (43–54)
Sex
 Male 936 (71)
 Female 387 (29)
Race
 Black 1085 (82)
 Non-Black 238 (18)
AUDIT category
 None 587 (44)
 Harmful/hazardous alcohol use 295 (23)
 Severe alcohol use/dependence 439 (33)
Injection drug use in previous 6 mo
 No 606 (46)
 Yes 714 (54)
Methadone use in previous 6 mo
 No 958 (73)
 Yes 362 (27)
BMI
 Underweight/normal 660 (51)
 Overweight 401 (31)
 Obese 238 (18)
Number of comorbidities §
 0 626 (47)
 1 554 (42)
 ≥2 135 (10)
HIV status
 Negative 867 (66)
 Positive, undetectable viral load 235 (18)
 Positive, detectable viral load 217 (16)
Median log LSM (IQR), kPa 1.95 (1.72–2.29)
LSM ≥12.3 kPa (cirrhosis)
 Yes 194 (15)
 No 1129 (85)

AUDIT = Alcohol Use Disorders Identification Test; BMI = body mass index; HCV = hepatitis C virus; LSM = liver stiffness measure.

*

Data are numbers (percentages) unless otherwise indicated. Some frequencies might not sum to the total because of missing values.

AUDIT scores between 8 and 14 were classified as harmful/hazardous alcohol use, and scores ≥15 were classified as severe alcohol use/dependence.

BMI <25 kg/m2 was classified as underweight/normal, 25–29.9 kg/m2 was classified as overweight, and ≥30 kg/m2 was classified as obese. Because there was a small number of underweight participants, they were grouped with those with normal weight.

§

Comorbidities were based on either 1) participants self-reporting that they had ever been told by a physician that they had kidney disease, diabetes, or hypertension, or 2) diagnostic criteria–based clinical/laboratory measurements (chronic kidney disease: estimated glomerular filtration rate <60 mL/min/1.73 m2; diabetes: hemoglobin A1c level >6.5%; hypertension: blood pressure >150/90 mm Hg for persons aged ≥60 y or >140/90 mm Hg for those aged <60 y).